Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$499M |
| 2 |
AT&T
T
|
+$462M |
| 3 |
Amazon
AMZN
|
+$257M |
| 4 |
Procter & Gamble
PG
|
+$219M |
| 5 |
Verizon
VZ
|
+$185M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$841M |
| 2 |
MON
Monsanto Co
MON
|
+$592M |
| 3 |
Apple
AAPL
|
+$140M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$110M |
| 5 |
Royal Bank of Canada
RY
|
+$81M |
Sector Composition
| 1 | Technology | 18.01% |
| 2 | Financials | 15.74% |
| 3 | Healthcare | 13.25% |
| 4 | Consumer Discretionary | 10.32% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWG
3151
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$148M
| $976K | ﹤0.01% |
85,694
+49,677
| +138% | +$566K |
|
3152
Veritone
VERI
$209M
| $974K | ﹤0.01% |
57,965
+13,743
| +31% | +$231K |
|
3153
Bandwidth Inc
BAND
$456M
| $971K | ﹤0.01% |
25,586
+4,112
| +19% | +$156K |
|
|
JMBA
3154
DELISTED
Jamba, Inc.
JMBA
| $970K | ﹤0.01% |
91,082
| – | – |
|
3155
Arcus Biosciences
RCUS
$1.24B
| $969K | ﹤0.01% |
+79,231
| New | +$969K |
|
3156
Fortress Biotech
FBIO
$115M
| $963K | ﹤0.01% |
21,553
+1,406
| +7% | +$62.8K |
|
3157
LSB Industries
LXU
$575M
| $957K | ﹤0.01% |
234,801
+15,989
| +7% | +$65.2K |
|
|
AAC
3158
DELISTED
AAC Holdings, Inc.
AAC
| $953K | ﹤0.01% |
101,801
+22,911
| +29% | +$214K |
|
3159
Forte Biosciences
FBRX
$136M
| $950K | ﹤0.01% |
272
+27
| +11% | +$94.3K |
|
|
EIGR
3160
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $947K | ﹤0.01% |
2,589
+1,819
| +236% | +$665K |
|
3161
Equinor
EQNR
$62.4B
| $944K | ﹤0.01% |
35,775
-2,220
| -6% | -$58.6K |
|
|
MCF
3162
DELISTED
Contango Oil & Gas Co.
MCF
| $944K | ﹤0.01% |
166,336
-25,830
| -13% | -$147K |
|
3163
Dr. Reddy's Laboratories
RDY
$12.1B
| $939K | ﹤0.01% |
148,095
+4,725
| +3% | +$30K |
|
|
ROX
3164
DELISTED
Castle Brands, Inc.
ROX
| $938K | ﹤0.01% |
788,428
+53,389
| +7% | +$63.5K |
|
3165
MEI Pharma
MEIP
$105M
| $937K | ﹤0.01% |
11,895
+1,688
| +17% | +$133K |
|
3166
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$590M
| $937K | ﹤0.01% |
69,068
-4,198
| -6% | -$57K |
|
|
FSTX
3167
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $932K | ﹤0.01% |
19,680
+7,164
| +57% | +$339K |
|
|
EMKR
3168
DELISTED
Emcore Corp
EMKR
| $930K | ﹤0.01% |
18,426
-5,919
| -24% | -$299K |
|
|
CEV
3169
Eaton Vance California Municipal Income Trust
CEV
$69.8M
| $928K | ﹤0.01% |
81,037
-32,297
| -28% | -$370K |
|
|
CLPR
3170
Clipper Realty
CLPR
$69.9M
| $928K | ﹤0.01% |
108,690
+6,305
| +6% | +$53.8K |
|
3171
Radware
RDWR
$1.09B
| $927K | ﹤0.01% |
36,680
+1,873
| +5% | +$47.3K |
|
3172
Biglari Holdings Class A
BH.A
$945M
| $926K | ﹤0.01% |
+975
| New | +$926K |
|
3173
Invesco Municipal Opportunity Trust
VMO
$637M
| $921K | ﹤0.01% |
78,504
-38,055
| -33% | -$446K |
|
|
PCOM
3174
DELISTED
Points.com Inc. Common Shares
PCOM
| $920K | ﹤0.01% |
55,938
+33,916
| +154% | +$558K |
|
3175
ImmunityBio
IBRX
$2.42B
| $918K | ﹤0.01% |
300,107
+12,518
| +4% | +$38.3K |
|